Create a narrative

BioLife Solutions Community

NasdaqCM:BLFS Community

1 Narratives written by author
0 Comments on narratives written by author
5 Fair Values set on narratives written by author

Create a narrative

BioLife Solutions

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 10 Analysts

Expanding Cell And Gene Therapy Workflows Will Shape Future Opportunities

Key Takeaways Market leadership in cell and gene therapy, combined with expanded high-value product offerings, drives strong revenue and margin growth opportunities. Acquisition-fueled innovation and resilient commercial revenue provide stability against biotech funding risks while improved pricing boosts profitability.

US$31.22

FV

31.4% undervalued

20.12%

Revenue growth p.a.

0

0

2

7 days ago